Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience
This clinical trial update discusses outcomes of new direct-acting antiviral agents for Hepatitis C in a community-based setting. The curren…
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir
A clinical trial evaluating boceprevir for Hepatitis C in Hispanic patients has been terminated. The study status is reported as TERMINATED.
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection [Phase 3]
Phase 3 trial assessing the efficacy and safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese participants with chronic genotype 1 hepati…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Directly Observed Hepatitis C Treatment in Methadone Clinics [NA]
This clinical trial evaluating directly observed hepatitis C treatment in methadone clinics has completed, sponsored by Albert Einstein Coll…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients [Phase 4]
Phase 4 clinical trial evaluating ribavirin pre-treatment followed by a combined standard therapy regimen in hepatitis C virus patients has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients [Phase 2]
An open-label Phase 2 study evaluated telaprevir in combination with ribavirin and pegylated interferon for hepatitis C in stable liver tran…
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C [Phase 4]
Phase 4 trial evaluating telaprevir with pegylated interferon alfa-2a and ribavirin in treatment-experienced genotype 1 chronic hepatitis C …
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy [NA]
An update on a clinical trial evaluating neurocognitive performance and emotional state in chronic hepatitis C patients treated with interfe…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Brief Intervention for Drug Misuse in the Emergency Department [Phase 2]
This update notes the completion of a Phase 2 trial evaluating a brief intervention for drug misuse delivered in the emergency department.
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Baclofen to Reduce Alcohol Use in Veterans With HCV [Phase 4]
Phase 4 trial evaluating baclofen to reduce alcohol use in veterans with hepatitis C; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002) [Phase 1]
This Phase 1 study reports safety, pharmacokinetics, and pharmacodynamics of MK-2248 in participants with hepatitis C, focusing on tolerabil…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C [Phase 4]
This Phase 4 clinical trial assesses the association between IL28B genotypes and clinical/demographic characteristics in both treatment-naïv…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV Infection [Phase 2]
Phase 2 trial update of ledipasvir/sofosbuvir fixed-dose combination in adults with nosocomial genotype 1 hepatitis C infection; study compl…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) [NA]
Completed clinical trial evaluating the effect of Agaricus blazei mushroom extract on hepatitis C and nutritional status.
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant [Phase 2]
Phase 2 trial evaluating whether pre-transplant sofosbuvir with ribavirin reduces hepatitis C recurrence after liver transplantation. The st…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone [Phase 2]
Phase 2 trial evaluating retreatment of chronic hepatitis C non-responders with pegylated interferon alfa-2a plus ribavirin and pioglitazone…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment [Phase 4]
A Phase 4 clinical trial update indicates that psychoeducation reaches hepatitis C patients on methadone or buprenorphine substitution durin…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Completed clinical trial evaluating whether resting-state default mode network fMRI maps can predict outcomes in hepatic encephalopathy rela…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection [Phase 3]
A Phase 3 trial evaluated Sofosbuvir plus Ribavirin for 12 or 24 weeks in treatment-naive and treatment-experienced Egyptian adults with chr…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: A Trial to Reduce Hepatitis C Among Injection Drug Users - 1 [Phase 3]
Phase 3 clinical trial aimed at reducing hepatitis C infection among injection drug users has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection [Phase 2]
Phase 2 trial evaluating a fixed-dose combination of ledipasvir/sofosbuvir with ribavirin or GS-9669 in Chronic Hepatitis C Virus infection …
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Effects of Ribavirin on Zidovudine or Stavudine
A completed clinical trial assessed the effects of adding ribavirin to zidovudine or stavudine therapy in patients with HIV infection and he…
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment [Phase 2]
A Phase 2 study evaluating Debio 025 (alisporivir) in combination with pegylated interferon alfa-2a and ribavirin in chronic hepatitis C pat…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults [Phase 3]
Phase 3 open-label trial evaluating the efficacy and safety of sofosbuvir plus ribavirin in adults co-infected with chronic hepatitis C and …
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001) [Phase 1, Phase 2]
Merck's IDX719, an NS5A inhibitor, was studied in healthy volunteers and patients with chronic hepatitis C in a Phase 1/2 trial (MK-1894-001…